IR Side Nav Overview Press Releases Events & Presentations Publications SEC Filings Financial Reports Annual Reports Quarterly Reports Financial Calendar Annual General Meeting Hauptversammlung Corporate Governance Analyst Coverage Stock Information Shareholder Fraud Warning Investor FAQ Media Materials Sign-up for Email Alerts Investor Contact Sylke Maas, Ph.D. VP Investor Relations & Business StrategySend Email +49 6131 9084-0 For U.S. Investors: Westwicke John WoolfordSend Email +1 443 213-0506 Media Contact Jasmina Alatovic Director Global External CommunicationsSend Email +49 6131 9084-0 Update on COVID-19 Vaccine Program Press Conference December 2, 2020 Click here for webcast Supporting Materials Update on COVID-19 Vaccine Program Press Conference 7.2 MB
Click here for webcast Supporting Materials Update on COVID-19 Vaccine Program Press Conference 7.2 MB
